Mizuho's Jared Holz joins 'Fast Money' to talk what is next for Novo Nordisk as the stock struggles.

Wall Street struggled to regain confidence in the wake of a Treasury selloff that shook markets amid fiscal concerns, with ...

Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss medications at ...

Wall Street showed signs of stabilization just a day after a Treasury selloff that shook markets around the globe, with stocks seeing small moves amid a rebound in bonds from session lows. The dollar ...

Blood and urine tests might be able to reveal how much of your diet is made up of industrially produced foods, a new study ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

On Wall Street, Charter Communications rose 1.8% after it said it agreed to merge with Cox Communications in a deal that ...

Novo Nordisk A/S NVO shares lost 2.7% on Friday after a surprising announcement regarding changes to its executive leadership ...

Novo Nordisk and GSK plc announced licensing deals with smaller biotechs. The FDA granted approval to Merck's drug, Welireg, ...

Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...

Most major stock indexes across the globe moved upwards on a weekly basis, taking support from the uptick in US equities.